Search results for "transmucosal"

showing 10 items of 13 documents

Soft tissue integration of different abutment surfaces: An experimental study with histological analysis

2021

OBJECTIVE To evaluate whether abutment surface and surface bio-activation have an effect on soft tissue morphogenesis. MATERIALS AND METHODS 36 patients (36 implants) were included. Abutments were randomly divided into 4 groups (n = 9): Smooth Surface-MAChined (MAC), Ultrathin Threaded Microsurface (UTM), MAC Plasma of Argon activated (Plasma-MAC), and UTM Plasma of Argon activated (Plasma-UTM). After 2 months of healing, soft tissue samples were collected and prepared for histological analysis. The margin of the peri-implant mucosa (PM), the apical extension of the barrier epithelium (aJE), and the apical location of the abutment (AM) were identified. Significances of differences among gro…

abutment0206 medical engineeringAbutmentConnective tissueDentistryPlasma treatmentDental Abutments02 engineering and technologyperi-implant attachmentsoft tissue adaptation03 medical and health sciences0302 clinical medicinebiologic widthmedicineHumansArgonDental ImplantsTitaniumbusiness.industryChemistryDental Implantation EndosseousSoft tissue030206 dentistry020601 biomedical engineeringEpitheliumddc:617.6Dental Implantationmedicine.anatomical_structureConnective Tissuetransmucosal collarOral Surgeryabutment; biologic width; peri-implant attachment; soft tissue adaptation; transmucosal collarbusinessEndosseousTooth
researchProduct

Radiological Outcomes of Bone-Level and Tissue-Level Dental Implants: Systematic Review

2020

Purpose: to assess any differences on marginal bone loss between bone-level or tissue-level dental implants through a review of literature until September 2019. Materials and methods: MEDLINE, Embase and other database were searched by two independent authors. The search was limited to articles in English. Results: The search provided 1028 records and, after removing the duplicates through titles and abstracts screening, 45 full-text articles were assessed for eligibility. For qualitative analysis 20 articles were included, 17 articles of them for quantitative analysis. A total of 1161 patients (mean age 54,4 years) and 2933 implants were observed, 1427 (Tissue-level) and 1506 (Bone-level).…

marginal bone lossbone-levelHealth Toxicology and MutagenesisMEDLINEAlveolar Bone Losslcsh:MedicineDentistryReviewtransmucosalBone and Bones03 medical and health sciences0302 clinical medicineQualitative analysissystematic reviewMedicineHumans030212 general & internal medicineDental Restoration FailureLongitudinal StudiesProspective StudiesBone levelSurvival rateRetrospective StudiesDental Implantstissue-leveldentistrybusiness.industrylcsh:RPublic Health Environmental and Occupational HealthTissue levelMean age030206 dentistryMiddle AgedRadiological weaponImplant typesbusiness
researchProduct

Potential transbuccal delivery of l-DOPA methylester prodrug: stability in the environment of the oral cavity and ability to cross the mucosal tissue

2016

Levodopa (l-DOPA) is the most effective pharmacologic agent in Parkinson's disease and remains the "gold standard". Nevertheless, in long-term treatments, dyskinesias and motor complications can emerge. In this work, the combined use of l-DOPA methylester hydrochloride prodrug (LDME) with transbuccal drug delivery was supposed as a good alternative method to optimize the bioavailability of l-DOPA, to maintain constant plasma levels and to decrease the drug unwanted effects. The effects of environmental pH on buccal delivery of LDME were evaluated ex vivo. The increase of pH value from 5.8 to 6.2 implies an improvement of drug permeation. Since the pH increase causes the raising of hydrolyti…

DrugHydrochloridemedia_common.quotation_subjectPharmaceutical Science02 engineering and technologyPharmacologyAntiparkinson AgentsLevodopachemical stability03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineDrug StabilitySettore MED/28 - Malattie OdontostomatologicheProdrugsmedia_commonBuccal permeationMouthintellidrug deviceMouth MucosaParkinson DiseaseGeneral MedicineBuccal administrationPermeationProdrug021001 nanoscience & nanotechnologytransmucosal drug deliveryBioavailabilitychemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryprodrug0210 nano-technology030217 neurology & neurosurgeryEx vivo
researchProduct

Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: a trial on pigs.

2010

Naltrexone (NLX), an opioid antagonist, is widely used in the treatment of opiate addiction, alcoholism and smoking cessation. Its current peroral administration induces various adverse side effects and has limited efficacy since bioavailability and patient compliance are poor. The development of a long-acting drug delivery system of NLX may overcome the current drawbacks and help in the improvement of treatment of addiction. The primary endpoints of this study were: a) to compare the NLX bioavailability and pharmacokinetics after delivering a single transbuccal dose, released by a prototype of intraoral device, versus an intravenous (I.V.) bolus of the same drug dose; b) to verify the func…

Naltrexone HydrochlorideSwineNarcotic AntagonistsSettore MED/50 - Scienze Tecniche Mediche ApplicatePharmaceutical ScienceBiological AvailabilityPharmacologyNaltrexoneBolus (medicine)Drug Delivery SystemsPharmacokineticsSettore MED/28 - Malattie OdontostomatologicheOral administrationMedicineAnimalsNaltrexone hydrochlorideIontophoresiNLXbusiness.industryNarcotic antagonistAdministration BuccalTransmucosal deliveryBuccal administrationEquipment DesignNaltrexoneSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoIntelliDrug intraoral deviceAnesthesiaFemalePorcine buccal mucosabusinessmedicine.drugJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailabili…

2017

Administered by an oral route, Furosemide (FUR), a diuretic used in several edematous states and hypertension, presents bioavailability problems, reported as a consequence of an erratic gastrointestinal absorption due to various existing polymorphic forms and low and pH-dependent solubility. A mucoadhesive sublingual fast-dissolving FUR based film has been developed and evaluated in order to optimize the bioavailability of FUR by increasing solubility and guaranteeing a good dissolution reproducibility. The Differential Scanning Calorimetry (DSC) analyses confirmed that the film prepared using the solvent casting method entrapped FUR in the amorphous state. As a solid dispersion, FUR increa…

Absorption (pharmacology)medicine.medical_specialtymucoadhesive filmMaterials scienceBioadhesivePharmaceutical Sciencelcsh:RS1-44102 engineering and technology030226 pharmacology & pharmacyArticleSublingual Absorptionlcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineDifferential scanning calorimetryamorphous solid dispersiontransmucosal deliverymedicineSolubilityDissolutionAmorphous solid dispersion; Furosemide bioavailability; Mucoadhesive film; Sublingual absorption; Transmucosal delivery;021001 nanoscience & nanotechnologyfurosemide bioavailabilityAmorphous solidSurgeryBioavailabilitysublingual absorptionChemical engineeringSettore CHIM/09 - Farmaceutico Tecnologico Applicativomucoadhesive film; sublingual absorption; amorphous solid dispersion; furosemide bioavailability; transmucosal delivery0210 nano-technologyPharmaceutics
researchProduct

Controlled delivery of naltrexone by an intraoral device: in vivo study on human subjects.

2013

Naltrexone is widely used in the treatment of opiate addiction but its current peroral administration is characterized by low bioavailability with various side effects. The development of a long-acting transbuccal delivery device (IntelliDrug) for NLX may be useful to improve patient compliance and the therapy effectiveness. The aims of the study are (a) to test basic safety and effectiveness of controlled transbuccal drug delivery on human subjects; (b) to compare NLX bioavailability following transbuccal delivery vs per os conventional delivery; and (c) to test the hypothesis that transbuccal delivery is more efficient than the conventional route. In this randomized cross-over pilot study…

Naltrexone HydrochlorideAdultMaleAdolescentNarcotic AntagonistsPharmaceutical ScienceAddictionBiological AvailabilityPharmacologySmoking cessationNaltrexonelaw.inventionTransbuccal drug deliveryYoung AdultDrug Delivery SystemsRandomized controlled triallawmedicineHumansNaltrexone hydrochlorideNLXCross-Over Studiesbusiness.industryAdministration BuccalTransmucosal deliveryBuccal administrationMiddle AgedCrossover studyNaltrexoneBioavailabilitySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAnesthesiaDelayed-Action PreparationsDrug deliveryMouth ProtectorsFemalebusinessmedicine.drugInternational journal of pharmaceutics
researchProduct

Buccal Thin Films as Potent Permeation Enhancers for Cytisine Transbuccal Delivery

2022

Cytisine (CYT) is a powerful anti-smoking compound which could greatly benefit from transbuccal delivery because of both its unfavorable pharmacokinetics after oral administration and its intrinsic ability to permeate the buccal mucosa. This work aims to design CYT-loaded buccal thin films suitable for transbuccal drug delivery due to its capability of promoting the interaction between CYT and the buccal membrane. The solvent casting method was employed to prepare several thin films combining various excipients such as matrixing polymers, mucoadhesion agents, plasticizers and other compounds as humectants and sweeteners, component ratios and solvents. A total of 36 compositions was prepared…

permeation enhancerdrug-membrane interactionbuccal filmSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoProcess Chemistry and Technologycytisinecytisine; buccal film; transmucosal drug delivery; drug-membrane interaction; permeability; mucoadhesion; permeation enhancer; ex vivo modelChemical Engineering (miscellaneous)Filtration and Separationpermeabilityex vivo modeltransmucosal drug deliverymucoadhesionMembranes; Volume 12; Issue 11; Pages: 1169
researchProduct

New horizons for OSCC chemotherapy: transmucosal permeability of 5-fluorouracil throughout porcine buccal mucosa

2007

buccal drug delivery5-fluouracilchemotherapytransmucosal permeability
researchProduct

In-Vitro Investigation of Fatigue and Fracture Behavior of Transmucosal versus Submerged Bone Level Implants Used in Fixed Prosthesis

2021

Background: The present in vitro study aimed to investigate the fatigue performance of different dental fixtures in two different emergence profiles. Biological failures are frequently reported because the problem canonly be solved by replacing a failing implant with a new one. Clinicians addressed minor mechanical failures, such as bending, loosening or the fracture of screws, abutment, or the entire prosthesis, by simply replacing or fixing them. Methods: Transmucosal and submerged bone-level dental implants underwent fatigue strength tests (statical and dynamical performance) by a standardized test: UNI EN ISO 14801:2016. Two types of emergence profiles (Premium sub-crestal straight impl…

TechnologyQH301-705.5QC1-999medicine.medical_treatmentProsthesis03 medical and health sciences0302 clinical medicinemedicineimplant fractureUltimate failureGeneral Materials ScienceBiology (General)QD1-999InstrumentationMathematicsFluid Flow and Transfer ProcessesOrthodonticstransmucosal implantTPhysicsProcess Chemistry and TechnologyGeneral EngineeringNonparametric statistics030206 dentistryfatigue testEngineering (General). Civil engineering (General)Fatigue limitComputer Science ApplicationsChemistryCoronal planeFracture (geology)ImplantTA1-2040submerged bone-level implant neckAbutment (dentistry)030217 neurology & neurosurgeryApplied Sciences
researchProduct

Novel Drug Delivery System for Treatment-Resistant Schizophrenia

2021

Settore CHIM/09 - Farmaceutico Tecnologico Applicativotreatment-resistant schizophrenia clozapine oral transmucosal delivery solid dosage form unidirectional delivery sustained release profile
researchProduct